Christoph M. Schempp

Prof. Christoph M. Schempp


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2008 in Molecules
Verified
Journal Article
Open access
PDF file
GSGünter Seelinger
Günter Seelinger
IMIrmgard Merfort
Irmgard Merfort
UWUte Wölfle
Ute Wölfle
CSChristoph M. Schempp
Christoph M. Schempp
Luteolin is a flavonoid which is part of our daily nutrition in relatively low amounts (less than 1 mg/day). Nevertheless, some epidemiological studies suggest an inverse correlation between luteolin intake and the risk of some cancer types. Luteolin displays specific anti-inflammatory and anti-carcinogenic effects, which can only partly be explained by its anti-oxidant and free radical scavenging capacities. Luteolin can delay or block the development of cancer cells in vitro and in vivo by protection from carcinogenic stimuli, by inhibition of tumor cell proliferation, by induction of cell cycle arrest and by induction of apoptosis via intrinsic and extrinsic signaling pathways. When compared to other flavonoids, luteolin was usually among the most effective ones, inhibiting tumor cell proliferation with IC50 values between 3 and 50 μM in vitro and in vivo by 5 to 10 mg/kg i.p., intragastric application of 0.1–0.3 mg/kg/d, or as food additive in concentrations of 50 to 200 ppm. Luteolin has been shown to penetrate into human skin, making it also a candidate for the prevention and treatment of skin cancer.

1 June 1999 in The Lancet
Verified
Journal Article
Closed access
CSChristoph M. Schempp
Christoph M. Schempp
KPKlaus Pelz
Klaus Pelz
AWAnnette Wittmer
Annette Wittmer
ESErwin Schöpf
Erwin Schöpf
Ján ŠimonJán Šimon
Ján Šimon

1 May 2010 in American Journal of Clinical Dermatology
Verified
Journal Article
Closed access
PDF file
JRJuliane Reuter
Juliane Reuter
IMIrmgard Merfort
Irmgard Merfort
CSChristoph M. Schempp
Christoph M. Schempp

1 January 2010 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
UWUte Wölfle
Ute Wölfle
MLMelanie N. Laszczyk
Melanie N. Laszczyk
MKMargarethe Kraus
Margarethe Kraus
KLKristina Leuner
Kristina Leuner
AKAstrid Kersten
Astrid Kersten
CSChristoph M. Schempp
Christoph M. Schempp

9 January 2019 in Molecules
Verified
Journal Article
Open access
PDF file
NWNatalja Weber
Natalja Weber
KBKlaus Biehler
Klaus Biehler
KSKay Schwabe
Kay Schwabe
BHBirgit Haarhaus
Birgit Haarhaus
KQKarl-Werner Quirin
Karl-Werner Quirin
UWUte Wölfle
Ute Wölfle
Acne is associated with hyperkeratosis, elevated levels of skin sebum and growth of Propionibacterium acnes (P. acnes) and Staphylococcus aureus (S. aureus). Furthermore, P. acnes promotes inflammation by inducing IL-6 production and oxidative stress. The aim of this study was to assess the antioxidant, anti-inflammatory and antibacterial potential of a hop-CO2-extract with 50% humulone and lupulone. The susceptibility of P. acnes and S. aureus to the hop extract was tested by using the broth microdilution technique. The minimal inhibitory concentrations (MIC) for P. acnes and S. aureus were 3.1 and 9.4 µg/mL, respectively. In addition, the hop extract showed an antioxidative effect with a half maximal inhibitory concentration (IC50) of 29.43 µg/mL as well as additional anti-inflammatory effects by reducing the IL-6 expression (IC50: 0.8 µg/mL). In addition, a gel formulation with 0.3% hop extract (w/w) had antibacterial activity against P. acnes and S. aureus (inhibition zone value: 5.5 mm and 3 mm, respectively) which was significantly superior to the placebo gel. The positive control (a gel with the antibiotic clindamycin) showed an inhibition zone of 9 mm. Due to its antioxidant, anti-inflammatory and antibacterial effects hop extract might be a treatment option for acne-prone skin.

8 February 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
JHJulia Hoffmann
Julia Hoffmann
FGFabian Gendrisch
Fabian Gendrisch
CSChristoph M. Schempp
Christoph M. Schempp
UWUte Wölfle
Ute Wölfle
Herbal extracts and isolated plant compounds play an increasing role in the treatment of skin disorders and wounds. Several new herbal drugs, medicinal products and cosmetic products for the treatment of various skin conditions have been developed in recent years. In this nonsystematic review, we focus on herbal drugs that were tested in controlled clinical studies or in scientifically sound preclinical studies. The herbal biomedicines are intended to treat atopic dermatitis (St. John’s wort, licorice, tormentil, bitter substances, evening primrose), psoriasis (araroba tree, lace flower, barberry bark, indigo, turmeric, olibanum, St. John’s wort), actinic keratosis (birch bark, petty spurge), herpes simplex (lemon balm, sage and rhubarb), rosacea (green tea, licorice, tormentil) and acne vulgaris (tea tree oil, green tea, hop), or to improve photo protection (green tea, Dyer’s weed, cocoa tree, carotinoids, licorice), aesthetic dermatology (licorice, pine bark, gotu kola) and wound healing (birch bark, onion).